Skip to main content
NCBI home page
Applied Microbiology logoLink to Applied Microbiology
. 1969 Aug;18(2):147–151. doi: 10.1128/am.18.2.147-151.1969

Influence of Statolon on Resistance of Mice to Influenza

Frank F Pindak 1, Jerome P Schmidt 1, Jerry Z Kendrick 1
PMCID: PMC377933  PMID: 4308934

Abstract

Various interferon inducers are known to elicit protection against lethal or infecting doses of certain viral agents. Because of the relatively high morbidity rate of influenza and its seasonal occurrence, we wished to determine whether statolon-induced interferon might be effective in controlling this disease. Mice were treated intraperitoneally with statolon and challenged with influenza A2 virus by the intranasal route. Although interferon was present in the serum at the time of virus administration, no change in mortality rate was observed. There was, however, a significant increase in the mean survival time of treated animals. Similar results were obtained when Newcastle disease virus was used as the interferon inducer. To determine the effect of the route of challenge, other mice were treated with statolon or Newcastle disease virus and inoculated with mengovirus by the intranasal or intraperitoneal route. The results demonstrated that the treated mice were protected to similar degree against challenge by either route. It is suggested that the relative ineffectiveness of interferon in protecting mice against influenza is due to an intrinsic characteristic of the virus itself rather than the type of interferon induced or the route of virus challenge.

Full text

PDF
147

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARON S., BUCKLER C. E. CIRCULATING INTERFERON IN MICE AFTER INTRAVENOUS INJECTION OF VIRUS. Science. 1963 Sep 13;141(3585):1061–1063. doi: 10.1126/science.141.3585.1061. [DOI] [PubMed] [Google Scholar]
  2. BARON S., ISAACS A. Absence of interferon in lungs fom fatal cases of influenza. Br Med J. 1962 Jan 6;1(5270):18–20. doi: 10.1136/bmj.1.5270.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Buckler C. E., Wong K. T., Baron S. Induction of the interferon system by various inducers. Proc Soc Exp Biol Med. 1968 Apr;127(4):1258–1262. doi: 10.3181/00379727-127-32924. [DOI] [PubMed] [Google Scholar]
  4. COCHRAN K. W., PAYNE F. E. SUSCEPTIBILITY OF A STRAIN OR RAT VIRUS TO STATOLON AND OTHER VIRUS INHIBITORS. Proc Soc Exp Biol Med. 1964 Feb;115:471–474. doi: 10.3181/00379727-115-28944. [DOI] [PubMed] [Google Scholar]
  5. ELLEM K. A., COLTER J. S. The isolation of three variants of Mengo virus differing in plaque morphology and hemagglutinating characteristics. Virology. 1961 Nov;15:340–347. doi: 10.1016/0042-6822(61)90365-8. [DOI] [PubMed] [Google Scholar]
  6. HITCHCOCK G., ISAACS A. Protection of mice against the lethal action of an encephalitis virus. Br Med J. 1960 Oct 29;2(5208):1268–1270. doi: 10.1136/bmj.2.5208.1268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HO M. Effect of an interferon on synthesis of viral ribonucleic acid and plaque formation. Proc Soc Exp Biol Med. 1963 Feb;112:511–515. doi: 10.3181/00379727-112-28090. [DOI] [PubMed] [Google Scholar]
  8. KLEINSCHMIDT W. J., CLINE J. C., MURPHY E. B. INTERFERON PRODUCTION INDUCED BY STATOLON. Proc Natl Acad Sci U S A. 1964 Sep;52:741–744. doi: 10.1073/pnas.52.3.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. KLEINSCHMIDT W. J., PROBST G. W. The nature of statolon, an antiviral agent. Antibiot Chemother (Northfield) 1962 May;12:298–309. [PubMed] [Google Scholar]
  10. Kleinschmidt W. J., Murphy E. B. Interferon induction with statolon in the intact animal. Bacteriol Rev. 1967 Jun;31(2):132–137. doi: 10.1128/br.31.2.132-137.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kleinschmidt W. J., Murphy E. B. Investigations on interferon induced by statolon. Virology. 1965 Dec;27(4):484–489. doi: 10.1016/0042-6822(65)90173-x. [DOI] [PubMed] [Google Scholar]
  12. LINK F., RAUS J. Multiplication of mouse-adapted influenza virus in mouse lungs after infection with very low doses. Nature. 1961 Nov 4;192:478–479. doi: 10.1038/192478a0. [DOI] [PubMed] [Google Scholar]
  13. Lackovic V., Borecký L., Sikl D., Masler L., Bauer S. The temperature requirement for interferon production in cells stimulated by Newcastle disease virus or microbial agents in vitro. Acta Virol. 1967 Nov;11(6):500–505. [PubMed] [Google Scholar]
  14. Merigan T. C., Gregory D. F., Petralli J. K. Physical properties of human interferon prepared in vitro and in vivo. Virology. 1966 Aug;29(4):515–522. doi: 10.1016/0042-6822(66)90276-5. [DOI] [PubMed] [Google Scholar]
  15. POWELL H. M., WALCHER D. N., MAST C. Antiviral action of statolon against Coxsackie A 21 (Coe) virus. Antibiot Chemother (Northfield) 1962 May;12:337–341. [PubMed] [Google Scholar]
  16. Pindak F. F., Schmidt J. P. Treatment of mengovirus infection in mice with statolon. Appl Microbiol. 1967 Sep;15(5):1240–1243. doi: 10.1128/am.15.5.1240-1243.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. SCHULMAN J. L., KILBOURNE E. D. Induction of viral interference in mice by aerosols of inactivated influenza virus. Proc Soc Exp Biol Med. 1963 Jun;113:431–435. doi: 10.3181/00379727-113-28387. [DOI] [PubMed] [Google Scholar]
  18. Schmidt J. P., Pindak F. F. Duration of prophylactic effect of statolon against mengovirus in mice. Appl Microbiol. 1968 Mar;16(3):468–469. doi: 10.1128/am.16.3.468-469.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Schmidt J. P., Pindak F. F. Statolon-induced resistance of mice to mengovirus. Appl Microbiol. 1967 May;15(3):654–656. doi: 10.1128/am.15.3.654-656.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Siegert R., Shu H. L., Kohlhage H. Correlation between fever and interferon titer in rabbits after induction with myxoviruses. Life Sci. 1967 Mar 15;6(6):615–620. doi: 10.1016/0024-3205(67)90097-5. [DOI] [PubMed] [Google Scholar]
  21. Subrahmanyan T. P., Mims C. A. Fate of intravenously administered interferon and the distribution of interferon during virus infections in mice. Br J Exp Pathol. 1966 Apr;47(2):168–176. [PMC free article] [PubMed] [Google Scholar]
  22. TAKANO K., JENSEN K. E., WARREN J. PASSIVE INTERFERON PROTECTION IN MOUSE INFLUENZA. Proc Soc Exp Biol Med. 1963 Nov;114:472–475. doi: 10.3181/00379727-114-28706. [DOI] [PubMed] [Google Scholar]
  23. WAGNER R. R. Cellular resistance to viral infection, with particular reference to endogenous interferon. Bacteriol Rev. 1963 Mar;27:72–86. doi: 10.1128/br.27.1.72-86.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wheelock E. F., Larke R. P. Efficacy of interferon in the treatment of mice with established Friend virus leukemia. Proc Soc Exp Biol Med. 1968 Jan;127(1):230–238. doi: 10.3181/00379727-127-32663. [DOI] [PubMed] [Google Scholar]
  25. Youngner J. S., Stinebring W. R. Comparison of interferon production in mice by bacterial endotoxin and statolon. Virology. 1966 Jun;29(2):310–316. doi: 10.1016/0042-6822(66)90038-9. [DOI] [PubMed] [Google Scholar]
  26. Youngner J. S., Stinebring W. R. Interferon appearance stimulated by endotoxin, bacteria, or viruses in mice pre-treated with Escherichia coli endotoxin or infected with Mycobacterium tuberculosis. Nature. 1965 Oct 30;208(5009):456–458. doi: 10.1038/208456a0. [DOI] [PubMed] [Google Scholar]

Articles from Applied Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES